Nateglinide (INN, trade name Starlix) is a drug for the treatment of type 2 diabetes
. Nateglinide was developed by Ajinomoto, a Japanese company and sold by ...
Easy to read patient leaflet for nateglinide. Includes indications, proper use,
special instructions, precautions, and possible side effects.
Starlix® (nateglinide) is an oral antidiabetic agent used in the management of
Type 2 diabetes mellitus [also known as non-insulin dependent diabetes mellitus
Learn about nateglinide (Starlix), a drug prescribed for the treatment of type 2
diabetes. Side effects, dosing, and drug interaction information is included.
Feb 15, 2014 ... Nateglinide Oral: learn about side effects, dosage, special precautions, and more
Medscape - Indication-specific dosing for Starlix (nateglinide), frequency-based
adverse effects, comprehensive interactions, contraindications, pregnancy ...
Nateglinide is an amino acid derivative that induces an early insulin response to
meals decreasing postprandial blood glucose levels. It should only be taken ...
Apr 17, 2015 ... Nateglinide (Starlix) is used to help lower blood sugar in people who have type 2
Nateglinide is a short-acting, pancreatic, beta-cell-selective, K(ATP) potassium
channel blocker that improves overall glycemic control in type 2 diabetes.
Find patient medical information for nateglinide oral on WebMD including its uses
, side effects and safety, interactions, pictures, warnings and user ratings.